Singapore
· Delayed Price · Currency is SGD Meta Health Statistics
Total Valuation
Meta Health has a market cap or net worth of SGD 5.28 million. The enterprise value is 7.15 million.
| Market Cap | 5.28M |
| Enterprise Value | 7.15M |
Important Dates
The last earnings date was Monday, February 23, 2026.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Meta Health has 1.32 billion shares outstanding. The number of shares has increased by 1.26% in one year.
| Current Share Class | 1.32B |
| Shares Outstanding | 1.32B |
| Shares Change (YoY) | +1.26% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.26% |
| Owned by Institutions (%) | 17.67% |
| Float | 1.02B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.72 |
| PB Ratio | -3.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.72 |
| EV / Sales | 5.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.53 |
Financial Position
The company has a current ratio of 0.47
| Current Ratio | 0.47 |
| Quick Ratio | 0.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.30 |
| Interest Coverage | -8.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -41.15% |
| Return on Invested Capital (ROIC) | -499.51% |
| Return on Capital Employed (ROCE) | 86.39% |
| Weighted Average Cost of Capital (WACC) | 7.15% |
| Revenue Per Employee | 1,645 |
| Profits Per Employee | -1,447 |
| Employee Count | 863 |
| Asset Turnover | 0.84 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is 0.70, so Meta Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 43.15 |
| Average Volume (20 Days) | 377,455 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Meta Health had revenue of SGD 1.42 million and -1.25 million in losses. Loss per share was -0.00.
| Revenue | 1.42M |
| Gross Profit | 1.33M |
| Operating Income | -1.12M |
| Pretax Income | -1.26M |
| Net Income | -1.25M |
| EBITDA | -1.11M |
| EBIT | -1.12M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 194,000 in cash and 2.18 million in debt, giving a net cash position of -1.99 million or -0.00 per share.
| Cash & Cash Equivalents | 194,000 |
| Total Debt | 2.18M |
| Net Cash | -1.99M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.47M |
| Book Value Per Share | -0.00 |
| Working Capital | -1.63M |
Cash Flow
In the last 12 months, operating cash flow was -945,000 and capital expenditures -4,000, giving a free cash flow of -949,000.
| Operating Cash Flow | -945,000 |
| Capital Expenditures | -4,000 |
| Free Cash Flow | -949,000 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 93.38%, with operating and profit margins of -78.66% and -87.96%.
| Gross Margin | 93.38% |
| Operating Margin | -78.66% |
| Pretax Margin | -88.52% |
| Profit Margin | -87.96% |
| EBITDA Margin | -78.31% |
| EBIT Margin | -78.66% |
| FCF Margin | n/a |
Dividends & Yields
Meta Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.26% |
| Shareholder Yield | -1.26% |
| Earnings Yield | -23.65% |
| FCF Yield | -17.97% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |